CME Group Inc. $CME Shares Bought by Czech National Bank

Czech National Bank raised its position in CME Group Inc. (NASDAQ:CME) by 5.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 103,140 shares of the financial services provider’s stock after buying an additional 4,933 shares during the quarter. Czech National Bank’s holdings in CME Group were worth $22,776,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of the company. Rehmann Capital Advisory Group boosted its holdings in shares of CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after acquiring an additional 37 shares in the last quarter. Asset Dedication LLC raised its holdings in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. Northwestern Mutual Investment Management Company LLC lifted its position in CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after purchasing an additional 37 shares during the period. Endowment Wealth Management Inc. lifted its position in CME Group by 4.4% in the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock worth $244,000 after purchasing an additional 38 shares during the period. Finally, NBT Bank N A NY boosted its stake in CME Group by 2.3% during the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock valued at $492,000 after purchasing an additional 38 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. TD Cowen lowered their price target on CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Rothschild & Co Redburn upgraded CME Group from a “neutral” rating to a “buy” rating and upped their price objective for the company from $316.00 to $323.00 in a report on Thursday, June 11th. JPMorgan Chase & Co. raised their target price on CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research note on Thursday, July 23rd. Piper Sandler lowered their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Finally, Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target on the stock in a research report on Thursday, June 18th. Eleven investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $291.81.

Insider Buying and Selling at CME Group

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the transaction, the insider directly owned 27,702 shares in the company, valued at $8,438,860.26. This trade represents a 17.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director William R. Shepard purchased 325 shares of the business’s stock in a transaction dated Thursday, June 25th. The shares were purchased at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the acquisition, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ CME opened at $263.66 on Friday. The stock’s fifty day simple moving average is $249.24 and its 200 day simple moving average is $280.78. The stock has a market capitalization of $94.81 billion, a price-to-earnings ratio of 22.36, a PEG ratio of 3.08 and a beta of 0.23. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.CME Group’s revenue was up .8% compared to the same quarter last year. During the same period in the prior year, the business posted $2.96 earnings per share. As a group, sell-side analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. CME Group’s dividend payout ratio is currently 44.11%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.